Valacyclovir oral suspension (Hyloris Pharmaceuticals)

Product Name :
Valacyclovir oral suspension (Hyloris Pharmaceuticals)

Search keywords :
Valacyclovir

drugId :
null

Target Vo:
Human herpesvirus 1 DNA polymerase

Target Vo Short Name :
UL30

Moa_Name:
Human herpesvirus 1 DNA polymerase inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Hyloris Pharmaceuticals

Active Company_Name :
Hyloris Pharmaceuticals

Active Indication_Name:
Virus Diseases

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Preclinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Cilgavimab Technical Information
TNF alpha Rabbit pAb manufacturer
SLC40A1 Antibody: SLC40A1 Antibody is an unconjugated, approximately 63 kDa, rabbit-derived, anti-SLC40A1 polyclonal antibody. SLC40A1 Antibody can be used for: WB, ELISA expriments in human, and predicted: mouse, rat, dog, pig, rabbit background without labeling.

Author: Betaine hydrochloride

Related Posts